Compulsorily Convertible Debentures cannot be considered as "Financial Debt" to initiate CIRP
M & A Critique|July 2023
Appeal is preferred by IFCI Limited ("Appellant") under Section 61 of the Insolvency and Bankruptcy Code, 2016 (hereinafter referred to as the 'Code') against the Impugned Order dated 14/03/2023 passed by the National Company Law Tribunal, Hyderabad Bench -||
Compulsorily Convertible Debentures cannot be considered as "Financial Debt" to initiate CIRP

Facts of the Case:

Before Initiation of CIRP

In 2011, IFCI agreed to provide financial assistance to the Corporate Debtor, IVRCL Chengapalli Tollways Ltd. (ICTL), through 'Compulsorily Convertible Debentures' ("CCDs") amounting to Rs. 125,00,00,000/- vide a Debenture Subscription Agreement (DSA) dated 14/10/2011.

IFCI, IVRCL Ltd (acting as Sponsor) and ICTL entered into a Share Buy Back Agreement, dated 14/10/2011, wherein the terms and conditions of the buyback of CCDS subscribed by the Applicant were detailed. The Applicant by exercising this option agreed to buy back Rs. 12.5 Crore CCDs any time between the end of the 3rd year and the 6th year from the date of issue of CCDs and in the event of default on behalf of ICTL, the Applicant would be at liberty to sell the CCDs to a third party.

In 2014, ICTL sought restructuring of the terms of repayment of the CCDs vide letter dated 21/11/2014 and the Applicant had approved restructuring of the CCD Facility.

In February 2017, ICTL suggested a 'One Time Settlement' ("OTS") and the Applicant agreed to the same on the condition that the amount of Rs. 135 crores shall be paid by 31/03/2017. On default, IFCI, revoked the Concession granted under restructuring of CCDs and therefore the OTS stood withdrawn. Subsequent to this, Corporate Guarantee of IVRCL was invoked by the Applicant. Subsequently, 'Corporate Insolvency Resolution Process' ("CIRP") was initiated by SBI against IVRCL on 23/02/2018.

The Applicant had filed its claim for Rs. 663.08 Cores, in relation to IVRCL's Corporate Guarantee Applications against IFCI's Facilities provided to ICTL

هذه القصة مأخوذة من طبعة July 2023 من M & A Critique.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة July 2023 من M & A Critique.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.

المزيد من القصص من M & A CRITIQUE مشاهدة الكل
Batliboi Ltd. merging its associate company
M & A Critique

Batliboi Ltd. merging its associate company

Batliboi Limited has a history of collaborations with various foreign technical partners and has subsidiaries like Hydraulic & General Engineers Ltd. and Batliboi International Ltd. In March 2024, the board of Directors of Batliboi Limited accorded their approval for the merger of promoter owned private company with itself.

time-read
2 mins  |
May 2024
TVS Motors issuances of convertible preference shares as bonus instead of dividend
M & A Critique

TVS Motors issuances of convertible preference shares as bonus instead of dividend

Recently, well known auto manufacturer announced the issuance of preference shares as a bonus to all equity shareholders.

time-read
3 mins  |
May 2024
Aditya Birla Fashion & Retails Scheme to undo its consolidation
M & A Critique

Aditya Birla Fashion & Retails Scheme to undo its consolidation

Corporate restructuring saga continues for Aditya Birla Group.

time-read
5 mins  |
May 2024
Advent International to combine its listed & private entity business
M & A Critique

Advent International to combine its listed & private entity business

Recently, Advent International announced the merger of its privately held pharma company into recently acquired listed pharma company.

time-read
6 mins  |
April 2024
Eris Lifesciences on Acquisition Spree to expand its branded formulations portfolio
M & A Critique

Eris Lifesciences on Acquisition Spree to expand its branded formulations portfolio

Recently, Eris Lifesciences Limited announced acquisition of 'branded Formulation Business' of Biocon Biologics Limited pertaining to the India territory through slump sale. In addition, ELL also announced a foreign acquisition.

time-read
7 mins  |
April 2024
Vuenow Merges All Entities Will It Create Value?
M & A Critique

Vuenow Merges All Entities Will It Create Value?

Recently, Vuenow Infratech Limited, a BSE listed company, announced the merger of two private companies itself.

time-read
6 mins  |
April 2024
Dalmia Group continues its journey of segregation of businesses by way of demerger
M & A Critique

Dalmia Group continues its journey of segregation of businesses by way of demerger

Recently Dalmia Group announced yet another restructuring of one of its group companies Dalmia Bharat Refractories Limited.

time-read
6 mins  |
March 2024
Rane Group to consolidate its listed operational entities
M & A Critique

Rane Group to consolidate its listed operational entities

After keeping different operational listed entities for years, Rane Group, one of the key players in Auto Ancillary space has decided to consolidate its listed operational companies under Rane (Madras) Limited.

time-read
3 mins  |
March 2024
Zuari Group's attempts to create the biggest private producer of Fertilisers
M & A Critique

Zuari Group's attempts to create the biggest private producer of Fertilisers

“Transfer of Identified shares from ZACL to ZMPPL is a precondition for approval of the merger transaction”

time-read
7 mins  |
March 2024
Shankara Building Products separates its trading & marketplace business for independent growth
M & A Critique

Shankara Building Products separates its trading & marketplace business for independent growth

Recently, Shankara Building Products Limited announced the demerger of its trading/building material marketplace business from its manufacturing business.

time-read
4 mins  |
February 2024